1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. PIRAMAL PHARMA LTD.
Piramal Pharma Ltd.
NSE: PPLPHARMA | BSE: 543635
US FDA Inspections
Ask MarketMind AI
218.68 3.73 (1.74%)
5.7M
NSE+BSE Volume

NSE 28 Aug, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert

Piramal Pharma - PPLPHARMA - stock price prediction, stock forecast, target price, analyst ratings from 11 analysts

Piramal Pharma has a share price target of Rs 233, revenue growth forecast of 15.4%, and profit growth estimate of 158.5% for FY27, based on top 11 analyst calls.